IPSC
Price
$0.58
Change
-$0.02 (-3.33%)
Updated
May 21, 04:59 PM (EDT)
Capitalization
51.7M
78 days until earnings call
NTLA
Price
$9.20
Change
-$0.47 (-4.86%)
Updated
May 21 closing price
Capitalization
952.97M
70 days until earnings call
Interact to see
Advertisement

IPSC vs NTLA

Header iconIPSC vs NTLA Comparison
Open Charts IPSC vs NTLABanner chart's image
Century Therapeutics
Price$0.58
Change-$0.02 (-3.33%)
Volume$11.16K
Capitalization51.7M
Intellia Therapeutics
Price$9.20
Change-$0.47 (-4.86%)
Volume$4.18M
Capitalization952.97M
IPSC vs NTLA Comparison Chart
Loading...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPSC vs. NTLA commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPSC is a StrongBuy and NTLA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (IPSC: $0.58 vs. NTLA: $9.20)
Brand notoriety: IPSC and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPSC: 129% vs. NTLA: 115%
Market capitalization -- IPSC: $51.7M vs. NTLA: $952.97M
IPSC [@Biotechnology] is valued at $51.7M. NTLA’s [@Biotechnology] market capitalization is $952.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPSC’s FA Score shows that 0 FA rating(s) are green whileNTLA’s FA Score has 1 green FA rating(s).

  • IPSC’s FA Score: 0 green, 5 red.
  • NTLA’s FA Score: 1 green, 4 red.
According to our system of comparison, NTLA is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPSC’s TA Score shows that 5 TA indicator(s) are bullish while NTLA’s TA Score has 5 bullish TA indicator(s).

  • IPSC’s TA Score: 5 bullish, 4 bearish.
  • NTLA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than IPSC.

Price Growth

IPSC (@Biotechnology) experienced а +18.50% price change this week, while NTLA (@Biotechnology) price change was +16.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.07%. For the same industry, the average monthly price growth was +10.40%, and the average quarterly price growth was -0.77%.

Reported Earning Dates

IPSC is expected to report earnings on Aug 07, 2025.

NTLA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+6.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($953M) has a higher market cap than IPSC($51.7M). NTLA YTD gains are higher at: -21.098 vs. IPSC (-42.614). IPSC has higher annual earnings (EBITDA): -117.21M vs. NTLA (-530.8M). NTLA has more cash in the bank: 504M vs. IPSC (198M). IPSC has less debt than NTLA: IPSC (54.6M) vs NTLA (119M). NTLA has higher revenues than IPSC: NTLA (45.6M) vs IPSC (2.68M).
IPSCNTLAIPSC / NTLA
Capitalization51.7M953M5%
EBITDA-117.21M-530.8M22%
Gain YTD-42.614-21.098202%
P/E RatioN/AN/A-
Revenue2.68M45.6M6%
Total Cash198M504M39%
Total Debt54.6M119M46%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IPSCNTLA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 8 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NLCAX48.26N/A
N/A
Voya Large-Cap Growth A
EDIIX10.98N/A
N/A
Eaton Vance Global Income Builder I
FMCAX42.78N/A
N/A
Fidelity Advisor Stock Selec Mid Cp M
SCIRX105.77N/A
N/A
Columbia Seligman Tech & Info R
RAAIX10.25N/A
N/A
Altegris/AACA Opportunistic Real Estt I

IPSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with CRSP. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
-3.40%
CRSP - IPSC
55%
Loosely correlated
-5.76%
IMNM - IPSC
50%
Loosely correlated
-7.48%
NTLA - IPSC
49%
Loosely correlated
-4.86%
ABCL - IPSC
49%
Loosely correlated
-4.78%
BEAM - IPSC
47%
Loosely correlated
-2.99%
More